AAAAAA

   
Results: 1-15 |
Results: 15
Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research
Authors: Bader, J Peters, J Baltatu, O Muller, DN Luft, FC Ganten, D
Citation: J. Bader et al., Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research, J MOL MED-J, 79(2-3), 2001, pp. 76-102
Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organdamage
Authors: Muller, DN Heissmeyer, V Dechend, R Hampich, F Park, JK Fiebeler, A Shagdarsuren, E Theuer, J Elger, M Pilz, B Breu, V Schroer, K Ganten, D Dietz, R Haller, H Scheidereit, C Luft, FC
Citation: Dn. Muller et al., Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organdamage, FASEB J, 15(8), 2001, pp. NIL_117-NIL_135
Renin uptake by the endothelium mediates vascular angiotensin formation
Authors: Hilgers, KF Veelken, R Muller, DN Kohler, H Hartner, A Botkin, SR Stumpf, C Schmieder, RE Gomez, RA
Citation: Kf. Hilgers et al., Renin uptake by the endothelium mediates vascular angiotensin formation, HYPERTENSIO, 38(2), 2001, pp. 243-248
Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes
Authors: Mervaala, EMA Cheng, ZJ Tikkanen, I Lapatto, R Nurminen, K Vapaatalo, H Muller, DN Fiebeler, A Ganten, U Ganten, D Luft, FC
Citation: Ema. Mervaala et al., Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes, HYPERTENSIO, 37(2), 2001, pp. 414-418
Mineralocorticoid receptor affects AP-1 and nuclear factor-kappa B activation in angiotensin II-Induced cardiac injury
Authors: Fiebeler, A Schmidt, F Muller, DN Park, JK Dechend, R Bieringer, M Shagdarsuren, E Breu, V Haller, H Luft, FC
Citation: A. Fiebeler et al., Mineralocorticoid receptor affects AP-1 and nuclear factor-kappa B activation in angiotensin II-Induced cardiac injury, HYPERTENSIO, 37(2), 2001, pp. 787-793
Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
Authors: Dechend, R Fiebeler, A Park, JK Muller, DN Theuer, J Mervaala, E Bieringer, M Gulba, D Dietz, R Luft, FC Haller, H
Citation: R. Dechend et al., Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, CIRCULATION, 104(5), 2001, pp. 576-581
Effect of bosentan on NF-kappa B, inflammation, and tissue factor in angiotensin II-induced end-organ damage
Authors: Muller, DN Mervaala, EMA Schmidt, F Park, JK Dechend, R Genersch, E Breu, V Loffler, BM Ganten, D Schneider, W Haller, H Luft, FC
Citation: Dn. Muller et al., Effect of bosentan on NF-kappa B, inflammation, and tissue factor in angiotensin II-induced end-organ damage, HYPERTENSIO, 36(2), 2000, pp. 282-290
Blood pressure-independent effects in rats with human renin and angiotensinogen genes
Authors: Mervaala, E Muller, DN Schmidt, F Park, JK Gross, V Bader, M Breu, V Ganten, D Haller, H Luft, FC
Citation: E. Mervaala et al., Blood pressure-independent effects in rats with human renin and angiotensinogen genes, HYPERTENSIO, 35(2), 2000, pp. 587-594
NF-kappa B inhibition ameliorates angiotensin II-induced inflammatory damage in rats
Authors: Muller, DN Dechend, R Mervaala, EMA Park, JK Schmidt, F Fiebeler, A Theuer, J Breu, V Ganten, D Haller, H Luft, FC
Citation: Dn. Muller et al., NF-kappa B inhibition ameliorates angiotensin II-induced inflammatory damage in rats, HYPERTENSIO, 35(1), 2000, pp. 193-201
Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes
Authors: Mervaala, E Muller, DN Park, JK Dechend, R Schmidt, F Fiebeler, A Bieringer, M Breu, V Ganten, D Haller, H Luft, FC
Citation: E. Mervaala et al., Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes, HYPERTENSIO, 35(1), 2000, pp. 360-366
Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects
Authors: Park, JK Muller, DN Mervaala, EMA Dechend, R Fiebeler, A Schmidt, F Bieringer, M Schafer, O Lindschau, C Schneider, W Ganten, D Luft, FC Haller, H
Citation: Jk. Park et al., Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects, KIDNEY INT, 58(4), 2000, pp. 1420-1430
Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor inangiotensin II-induced cardiac vasculopathy
Authors: Muller, DN Mervaala, EMA Dechend, R Fiebeler, A Park, JK Schmidt, F Theuer, J Breu, V Mackman, N Luther, T Schneider, W Gulba, D Ganten, D Haller, H Luft, FC
Citation: Dn. Muller et al., Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor inangiotensin II-induced cardiac vasculopathy, AM J PATH, 157(1), 2000, pp. 111-122
Hypertension-induced end-organ damage - A new transgenic approach to an old problem
Authors: Luft, FC Mervaala, E Muller, DN Gross, V Schmidt, F Park, JK Schmitz, C Lippoldt, A Breu, V Dechend, R Dragun, D Schneider, W Ganten, D Haller, H
Citation: Fc. Luft et al., Hypertension-induced end-organ damage - A new transgenic approach to an old problem, HYPERTENSIO, 33(1), 1999, pp. 212-218
Effects of human prorenin in rats transgenic for human angiotensinogen
Authors: Muller, DN Hilgers, KF Mathews, S Breu, V Fischli, W Uhlmann, R Luft, FC
Citation: Dn. Muller et al., Effects of human prorenin in rats transgenic for human angiotensinogen, HYPERTENSIO, 33(1), 1999, pp. 312-317
Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension
Authors: Mervaala, EMA Muller, DN Park, JK Schmidt, F Lohn, M Breu, V Dragun, D Ganten, D Haller, H Luft, FC
Citation: Ema. Mervaala et al., Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension, HYPERTENSIO, 33(1), 1999, pp. 389-395
Risultati: 1-15 |